Viewing Study NCT04923932


Ignite Creation Date: 2025-12-24 @ 9:44 PM
Ignite Modification Date: 2026-01-02 @ 11:03 AM
Study NCT ID: NCT04923932
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-05-23
First Post: 2021-05-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Savolitinib for Treating Gastric Cancer and Esophagogastric Junction Adenocarcinoma Patients
Sponsor: Hutchison Medipharma Limited
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 2020-504-00CH1
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators